« Back to Record
Citation APA

Martin, M., Bonneterre, J., Geyer Jr., C. C., Ito, Y., Ro, J., Lang, I., Kim, S.-B., Germa, C., Vermette, J., Wang, K., Wang, K., & Awada, A. (2013). A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer. European journal of cancer, 49(18), 3763-3772. doi:10.1016/j.ejca.2013.07.142


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168190

Martin, M., Bonneterre, J., Geyer Jr., C. C., Ito, Y., Ro, J., Lang, I., Kim, S.-B., Germa, C., Vermette, J., Wang, K., Wang, K., & Awada, A. (2013). A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer. European journal of cancer, 49(18), 3763-3772. doi:10.1016/j.ejca.2013.07.142